{"id":"placebo-for-rosuvastatin","safety":{"commonSideEffects":[{"rate":"null","effect":"Muscle pain"},{"rate":"null","effect":"Liver enzyme elevation"},{"rate":"null","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting HMG-CoA reductase, rosuvastatin reduces the liver's production of low-density lipoprotein (LDL) cholesterol, also known as 'bad' cholesterol. This leads to an increase in high-density lipoprotein (HDL) cholesterol, or 'good' cholesterol, and a decrease in triglycerides. The net effect is a reduction in the risk of cardiovascular events such as heart attacks and strokes.","oneSentence":"Rosuvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:26.084Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"},{"name":"Hyperlipidemia"}]},"trialDetails":[{"nctId":"NCT05850091","phase":"PHASE4","title":"Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-12-07","conditions":"Coronary Artery Disease","enrollment":200},{"nctId":"NCT07216482","phase":"PHASE3","title":"A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-11-11","conditions":"Hyperlipidemia","enrollment":975},{"nctId":"NCT07218900","phase":"PHASE2","title":"A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With Dyslipidaemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-11-13","conditions":"Dyslipidaemia","enrollment":76},{"nctId":"NCT06834932","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-12-06","conditions":"Dyslipidaemia","enrollment":360},{"nctId":"NCT04098003","phase":"PHASE4","title":"Investigation of the Gut Microbiome and Statin Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sony Tuteja","startDate":"2020-02-06","conditions":"Healthy Volunteers","enrollment":62},{"nctId":"NCT07232069","phase":"PHASE3","title":"PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-07-01","conditions":"Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression, Prevention & Control","enrollment":1500},{"nctId":"NCT05912387","phase":"EARLY_PHASE1","title":"Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-05-31","conditions":"Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases","enrollment":15},{"nctId":"NCT06538649","phase":"EARLY_PHASE1","title":"Effect of Statins on Crohn's Disease","status":"RECRUITING","sponsor":"Stanford University","startDate":"2024-12-12","conditions":"Crohn's Ileocolitis, Crohn Disease","enrollment":20},{"nctId":"NCT03016819","phase":"PHASE3","title":"Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)","status":"RECRUITING","sponsor":"Advenchen Laboratories, LLC","startDate":"2017-08-15","conditions":"Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma","enrollment":325},{"nctId":"NCT06981299","phase":"PHASE1","title":"A Phase 1 Study of PROT-001.","status":"COMPLETED","sponsor":"Protego Biopharma Pty Ltd","startDate":"2025-05-29","conditions":"Healthy","enrollment":102},{"nctId":"NCT04319627","phase":"PHASE3","title":"Statins for Venous Event Reduction in Patients With Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-02-10","conditions":"Venous Thromboembolism, Blood Clot, Post Thrombotic Syndrome","enrollment":2700},{"nctId":"NCT05832229","phase":"PHASE2","title":"Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-12-07","conditions":"Cirrhosis, Cirrhosis, Liver, Cirrhosis Early","enrollment":256},{"nctId":"NCT07303816","phase":"PHASE4","title":"Statins to Prevent Cancer Associated Blood Clots","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-04-01","conditions":"Venous Thromboembolism, Cancer, Cardiovascular Events","enrollment":4000},{"nctId":"NCT06317051","phase":"PHASE3","title":"Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kirby Institute","startDate":"2024-12-16","conditions":"HIV Infections, Weight Gain","enrollment":300},{"nctId":"NCT07254221","phase":"PHASE4","title":"Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Shiraz University of Medical Sciences","startDate":"2026-02-01","conditions":"Anthracycline-induced Cardiac Toxicity, Breast Cancer, Anthracycline Related Cardiotoxicity in Breast Cancer","enrollment":400},{"nctId":"NCT06742853","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-12-20","conditions":"Dyslipidemia","enrollment":81},{"nctId":"NCT04669041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2020-12-08","conditions":"Hypercholesterolemia","enrollment":305},{"nctId":"NCT06603363","phase":"NA","title":"Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT","status":"RECRUITING","sponsor":"Prof. Maurovich-Horvat Pál","startDate":"2025-05-28","conditions":"Coronary Artery Disease, Atherosclerotic Plaque, Coronary Computed Tomography Angiography","enrollment":140},{"nctId":"NCT06279234","phase":"PHASE1","title":"A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-02-20","conditions":"Type 2 Diabetes Mellitus (T2DM), Obesity","enrollment":50},{"nctId":"NCT06048588","phase":"PHASE1, PHASE2","title":"YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis","status":"COMPLETED","sponsor":"Beijing Inno Medicine Co., Ltd.","startDate":"2023-10-08","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":144},{"nctId":"NCT06533280","phase":"PHASE1","title":"VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)","status":"WITHDRAWN","sponsor":"ViiV Healthcare","startDate":"2024-08-02","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT06924684","phase":"PHASE2","title":"High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sheikh Zayed Federal Postgraduate Medical Institute","startDate":"2024-12-02","conditions":"ST Elevation (STEMI) Myocardial Infarction","enrollment":66},{"nctId":"NCT04542382","phase":"PHASE1","title":"Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-10-28","conditions":"Healthy Volunteers","enrollment":11},{"nctId":"NCT06804980","phase":"PHASE4","title":"DESIFOR-EXPAND (MHIF)","status":"RECRUITING","sponsor":"Minneapolis Heart Institute Foundation","startDate":"2025-02-01","conditions":"Statin Therapy, Statin Adverse Reaction, Statin","enrollment":100},{"nctId":"NCT05155137","phase":"PHASE3","title":"Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)","status":"RECRUITING","sponsor":"Hospital Moinhos de Vento","startDate":"2021-12-20","conditions":"Stroke, Cognitive Decline","enrollment":8518},{"nctId":"NCT06036784","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects","status":"COMPLETED","sponsor":"MBX Biosciences","startDate":"2023-09-18","conditions":"Postbariatric Hypoglycemia","enrollment":69},{"nctId":"NCT02741245","phase":"PHASE3","title":"A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2016-06-09","conditions":"Hypercholesterolemia","enrollment":321},{"nctId":"NCT02008786","phase":"PHASE4","title":"Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD","status":"TERMINATED","sponsor":"Cardiology Research UBC","startDate":"2014-06","conditions":"Coronary Artery Dissection, Spontaneous","enrollment":18},{"nctId":"NCT06304896","phase":"PHASE1","title":"Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Arab Contractors Medical Centre","startDate":"2024-05-01","conditions":"Chemotherapy Induced Systolic Dysfunction","enrollment":150},{"nctId":"NCT04931147","phase":"PHASE1","title":"A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers","status":"COMPLETED","sponsor":"Redx Pharma Ltd","startDate":"2021-05-13","conditions":"Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis","enrollment":90},{"nctId":"NCT01011478","phase":"PHASE3","title":"Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery","status":"TERMINATED","sponsor":"NSABP Foundation Inc","startDate":"2010-03","conditions":"Colorectal Cancer, Precancerous Condition","enrollment":406},{"nctId":"NCT03510884","phase":"PHASE3","title":"An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-31","conditions":"Hypercholesterolaemia","enrollment":153},{"nctId":"NCT02901067","phase":"PHASE2","title":"STAT-STatin and Aspirin in Trauma","status":"TERMINATED","sponsor":"Denver Health and Hospital Authority","startDate":"2017-02-03","conditions":"Wounds and Injuries, Venous Thromboembolism","enrollment":43},{"nctId":"NCT01763866","phase":"PHASE3","title":"LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-15","conditions":"Hyperlipidemia","enrollment":2067},{"nctId":"NCT02850081","phase":"PHASE3","title":"Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-06-01","conditions":"Carotid Artery Stenosis, Strokes","enrollment":31},{"nctId":"NCT05373277","phase":"PHASE1","title":"KF2019#1-trial: Effects of a Thrombocyte Inhibitor on a Cholesterol-lowering Drug","status":"UNKNOWN","sponsor":"Helsinki University Central Hospital","startDate":"2022-05-11","conditions":"Pharmacokinetics","enrollment":10},{"nctId":"NCT03847506","phase":"PHASE4","title":"Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets","status":"COMPLETED","sponsor":"HK inno.N Corporation","startDate":"2018-07-05","conditions":"Hypertension, Hyperlipidemia","enrollment":127},{"nctId":"NCT01047501","phase":"PHASE3","title":"Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":702},{"nctId":"NCT01047683","phase":"PHASE3","title":"Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2009-12","conditions":"Hypertriglyceridemia","enrollment":229},{"nctId":"NCT01492361","phase":"PHASE3","title":"A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin","status":"COMPLETED","sponsor":"Amarin Pharma Inc.","startDate":"2011-11","conditions":"Cardiovascular Diseases","enrollment":8179},{"nctId":"NCT02476006","phase":"PHASE3","title":"Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-06-23","conditions":"Hypercholesterolemia","enrollment":998},{"nctId":"NCT03889314","phase":"PHASE4","title":"The DEtermining Statin Intolerance FOr Rosuvastatin (DESIFOR) Trial","status":"UNKNOWN","sponsor":"Minneapolis Heart Institute Foundation","startDate":"2019-04-26","conditions":"Cardiovascular Risk Factor, Cardiovascular Diseases, Adverse Effect","enrollment":25},{"nctId":"NCT00651144","phase":"PHASE1","title":"Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-03","conditions":"Hypercholesterolemia, Atherosclerosis","enrollment":40},{"nctId":"NCT03113994","phase":"PHASE2","title":"Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk","status":"UNKNOWN","sponsor":"Dr. B. Catharine. Craven","startDate":"2018-02-26","conditions":"Spinal Cord Injuries, Osteoporosis, Metabolic Syndrome","enrollment":8},{"nctId":"NCT02586155","phase":"PHASE3","title":"Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD","status":"COMPLETED","sponsor":"Resverlogix Corp","startDate":"2015-11","conditions":"Diabetes Mellitus, Type 2, Coronary Artery Disease","enrollment":2425},{"nctId":"NCT02482207","phase":"PHASE4","title":"Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2015-11","conditions":"Hypertension","enrollment":96},{"nctId":"NCT01881971","phase":"EARLY_PHASE1","title":"Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center","status":"COMPLETED","sponsor":"Alison Morris","startDate":"2013-05","conditions":"HIV Seropositivity","enrollment":23},{"nctId":"NCT01730053","phase":"PHASE3","title":"Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-11-30","conditions":"Hypercholesterolemia","enrollment":305},{"nctId":"NCT04328064","phase":"NA","title":"The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease","status":"COMPLETED","sponsor":"University of Alexandria","startDate":"2010-05","conditions":"Behcet's Disease","enrollment":56},{"nctId":"NCT02546323","phase":"PHASE3","title":"A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-09-17","conditions":"Atherosclerosis","enrollment":543},{"nctId":"NCT00679510","phase":"PHASE2, PHASE3","title":"Rosuvastatin in Rheumatoid Arthritis (RORA)","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2004-02","conditions":"Rheumatoid Arthritis","enrollment":50},{"nctId":"NCT02715726","phase":"PHASE3","title":"Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-27","conditions":"Hypercholesterolemia","enrollment":615},{"nctId":"NCT01890967","phase":"PHASE2","title":"A Study of LY3015014 in Participants With High Cholesterol","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2013-06","conditions":"Hypercholesterolemia","enrollment":527},{"nctId":"NCT01663402","phase":"PHASE3","title":"ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-10","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":18924},{"nctId":"NCT01863914","phase":"PHASE2","title":"Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2012-11","conditions":"End-stage Kidney Disease, Diabetes Mellitus, Arteriovenous Fistula","enrollment":60},{"nctId":"NCT02977065","phase":"PHASE2","title":"To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2017-03-23","conditions":"Dyslipidemias","enrollment":62},{"nctId":"NCT01051401","phase":"PHASE1","title":"Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2010-01","conditions":"Cardiovascular Complications, Recurrent Breast Cancer, Stage I Breast Cancer","enrollment":5},{"nctId":"NCT01524653","phase":"PHASE2","title":"Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2012-03","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Neoplasms","enrollment":38},{"nctId":"NCT03088254","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin","status":"COMPLETED","sponsor":"Jeil Pharmaceutical Co., Ltd.","startDate":"2016-09-20","conditions":"Dyslipidemia With Hypertension","enrollment":126},{"nctId":"NCT00978419","phase":"PHASE2","title":"Pilot Trial of Statin Use in Burn Patients","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2010-03","conditions":"Burns","enrollment":40},{"nctId":"NCT02546648","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study","status":"COMPLETED","sponsor":"McMaster University","startDate":"2015-02","conditions":"Atherosclerotic Disease, Perioperative Bleeding","enrollment":100},{"nctId":"NCT01105975","phase":"PHASE2","title":"A Study of LY2484595 in Patients With High LDL-C or Low HDL-C","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-04","conditions":"Dyslipidemia","enrollment":398},{"nctId":"NCT02434497","phase":"PHASE3","title":"A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-06-06","conditions":"Homozygous Familial Hypercholesterolemia (HoFH)","enrollment":9},{"nctId":"NCT01153334","phase":"PHASE4","title":"Efficacy of Early Intensive ROsuvastatin Therapy in Patients With ST-segment Elevation Myocardial Infarction Undergoing PrimARY Percutaneous Coronary Intervention (the ROSEMARY Trial)","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-08-02","conditions":"ST-segment Elevation AMI","enrollment":125},{"nctId":"NCT00127218","phase":"PHASE3","title":"High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2003-09","conditions":"Atherosclerosis, Cardiovascular Disease","enrollment":145},{"nctId":"NCT03204058","phase":"PHASE2, PHASE3","title":"Locally Delivered Metformin & Rosuvastatin for Treatment of Intrabony Defects in Chronic Periodontitis","status":"COMPLETED","sponsor":"Government Dental College and Research Institute, Bangalore","startDate":"2016-02-10","conditions":"Chronic Periodontitis","enrollment":90},{"nctId":"NCT02289963","phase":"PHASE3","title":"Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-01","conditions":"Hypercholesterolemia","enrollment":199},{"nctId":"NCT01702987","phase":"NA","title":"Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2012-10","conditions":"Myopathy, HMG COA Reductase Inhibitor Adverse Reaction, Hypercholesterolemia","enrollment":22},{"nctId":"NCT01241903","phase":"PHASE1","title":"Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions","status":"COMPLETED","sponsor":"Susan Smyth","startDate":"2011-06","conditions":"Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Hydroxymethylglutaryl-CoA Reductase Inhibitors","enrollment":54},{"nctId":"NCT00970606","phase":"NA","title":"STIP: Statin Trial for Influenza Patients","status":"TERMINATED","sponsor":"Gordon Bernard","startDate":"2009-10","conditions":"Acute Respiratory Distress Syndrome, Influenza, H1N1 Influenza","enrollment":7},{"nctId":"NCT01926782","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2013-09","conditions":"Hypercholesterolemia","enrollment":803},{"nctId":"NCT00850460","phase":"PHASE4","title":"Quality of Life in Patients With Statin-Associated Myopathy","status":"TERMINATED","sponsor":"Rockefeller University","startDate":"2009-02","conditions":"Statin Adverse Reaction","enrollment":14},{"nctId":"NCT02107898","phase":"PHASE3","title":"Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2014-03","conditions":"Hypercholesterolemia","enrollment":216},{"nctId":"NCT01617655","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-06","conditions":"Hypercholesterolaemia","enrollment":107},{"nctId":"NCT01582165","phase":"PHASE4","title":"Women With Chest Pain and no Significant Coronary Artery Stenosis; A Study on Microvascular Resistance","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2012-06","conditions":"Angina Pectoris","enrollment":66},{"nctId":"NCT01644188","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-08","conditions":"Hypercholesterolemia","enrollment":720},{"nctId":"NCT02226198","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11","conditions":"Homozygous Familial Hypercholesterolemia (HoFH)","enrollment":20},{"nctId":"NCT00532311","phase":"PHASE3","title":"Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia","status":"TERMINATED","sponsor":"Takeda","startDate":"2007-07","conditions":"Hypercholesterolemia","enrollment":411},{"nctId":"NCT02800902","phase":"PHASE2, PHASE3","title":"Locally Delivered Atorvastatin & Rosuvastatin for Treatment of Furcation Defects in Chronic Periodontitis","status":"COMPLETED","sponsor":"Government Dental College and Research Institute, Bangalore","startDate":"2015-05","conditions":"Chronic Periodontitis","enrollment":90},{"nctId":"NCT00979121","phase":"PHASE3","title":"Statins for Acutely Injured Lungs From Sepsis","status":"TERMINATED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-01","conditions":"Sepsis, Acute Lung Injury","enrollment":745},{"nctId":"NCT01218802","phase":"PHASE2","title":"Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2011-02","conditions":"HIV Infections, Heart Disease","enrollment":147},{"nctId":"NCT01623115","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-07","conditions":"Hypercholesterolemia","enrollment":486},{"nctId":"NCT01507831","phase":"PHASE3","title":"Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-01","conditions":"Hypercholesterolemia","enrollment":2341},{"nctId":"NCT01644175","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-07","conditions":"Hypercholesterolemia","enrollment":316},{"nctId":"NCT01709500","phase":"PHASE3","title":"Study of Alirocumab (REGN727/SAR236553) in Patients With heFH (Heterozygous Familial Hypercholesterolemia) Who Are Not Adequately Controlled With Their LMT (Lipid-Modifying Therapy)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-12","conditions":"Heterozygous Familial Hypercholesterolemia","enrollment":249},{"nctId":"NCT02551172","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2014-10","conditions":"Hyperlipidemias","enrollment":270},{"nctId":"NCT01730040","phase":"PHASE3","title":"Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2012-10","conditions":"Hypercholesterolemia","enrollment":355},{"nctId":"NCT01068626","phase":"PHASE3","title":"Rosuvastatin in Visceral Adiposity","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2006-05","conditions":"Abdominal Obesity","enrollment":54},{"nctId":"NCT01170585","phase":"PHASE2","title":"A Trial of Rosuvastatin in Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2010-07","conditions":"Atherosclerosis, Systemic Lupus Erythematosus","enrollment":33},{"nctId":"NCT02445352","phase":"PHASE3","title":"Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2014-07","conditions":"Primary Hypercholesterolemia","enrollment":379},{"nctId":"NCT01918332","phase":"PHASE3","title":"Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia","status":"COMPLETED","sponsor":"LG Life Sciences","startDate":"2012-04","conditions":"Hypertension,, Hyperlipidemia","enrollment":168},{"nctId":"NCT00913562","phase":"PHASE4","title":"Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma","status":"WITHDRAWN","sponsor":"Medical University of Vienna","startDate":"2009-06","conditions":"Glaucoma, Diabetes","enrollment":""},{"nctId":"NCT01364220","phase":"PHASE3","title":"The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke","status":"TERMINATED","sponsor":"Severance Hospital","startDate":"2010-08","conditions":"Stroke","enrollment":318},{"nctId":"NCT02205775","phase":"PHASE3","title":"Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary Angioplasty","status":"TERMINATED","sponsor":"G. d'Annunzio University","startDate":"2010-05","conditions":"Stable Coronary Artery Disease Undergoing PCI","enrollment":280},{"nctId":"NCT02129231","phase":"PHASE2","title":"Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2012-02","conditions":"Oxidative Stress, Diabetic Polyneuropathy","enrollment":74},{"nctId":"NCT02087540","phase":"PHASE3","title":"Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia","status":"UNKNOWN","sponsor":"IlDong Pharmaceutical Co Ltd","startDate":"2013-05","conditions":"Hypertension, Hyperlipidemia","enrollment":310},{"nctId":"NCT00505154","phase":"PHASE3","title":"Effect of Rosuvastatin on Left Ventricular Remodeling","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2007-07","conditions":"Dilated Cardiomyopathy","enrollment":75},{"nctId":"NCT01764295","phase":"PHASE3","title":"Clinical Study for Patients With Hypertension Associated With Dyslipidemia","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2012-09","conditions":"Hypertension, Dyslipidemia","enrollment":150},{"nctId":"NCT01624857","phase":"PHASE3","title":"Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2012-06","conditions":"Coronary Heart Disease","enrollment":400},{"nctId":"NCT01899027","phase":"PHASE4","title":"Rosuvastatin for Preventing Complications in Renal Ablation","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2014-01","conditions":"Arterial Hypertension","enrollment":112}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":521,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for Rosuvastatin","genericName":"Placebo for Rosuvastatin","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rosuvastatin is a statin that inhibits HMG-CoA reductase, a key enzyme in cholesterol synthesis. Used for Hypercholesterolemia, Hyperlipidemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}